1. Home
  2. PHR vs EVO Comparison

PHR vs EVO Comparison

Compare PHR & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHR
  • EVO
  • Stock Information
  • Founded
  • PHR 2005
  • EVO 1993
  • Country
  • PHR United States
  • EVO Germany
  • Employees
  • PHR N/A
  • EVO N/A
  • Industry
  • PHR Business Services
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • PHR Consumer Discretionary
  • EVO Health Care
  • Exchange
  • PHR Nasdaq
  • EVO Nasdaq
  • Market Cap
  • PHR 1.5B
  • EVO 1.5B
  • IPO Year
  • PHR 2019
  • EVO 2021
  • Fundamental
  • Price
  • PHR $27.16
  • EVO $4.07
  • Analyst Decision
  • PHR Strong Buy
  • EVO Buy
  • Analyst Count
  • PHR 12
  • EVO 2
  • Target Price
  • PHR $31.50
  • EVO $5.90
  • AVG Volume (30 Days)
  • PHR 647.3K
  • EVO 112.1K
  • Earning Date
  • PHR 09-03-2025
  • EVO 08-13-2025
  • Dividend Yield
  • PHR N/A
  • EVO N/A
  • EPS Growth
  • PHR N/A
  • EVO N/A
  • EPS
  • PHR N/A
  • EVO N/A
  • Revenue
  • PHR $434,532,000.00
  • EVO $851,944,444.00
  • Revenue This Year
  • PHR $14.74
  • EVO $10.08
  • Revenue Next Year
  • PHR $11.57
  • EVO $10.99
  • P/E Ratio
  • PHR N/A
  • EVO N/A
  • Revenue Growth
  • PHR 16.29
  • EVO 1.50
  • 52 Week Low
  • PHR $17.07
  • EVO $2.84
  • 52 Week High
  • PHR $30.53
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • PHR 48.19
  • EVO 47.66
  • Support Level
  • PHR $28.17
  • EVO $4.12
  • Resistance Level
  • PHR $29.26
  • EVO $4.26
  • Average True Range (ATR)
  • PHR 0.97
  • EVO 0.11
  • MACD
  • PHR -0.08
  • EVO -0.01
  • Stochastic Oscillator
  • PHR 43.43
  • EVO 54.84

About PHR Phreesia Inc.

Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: